IntelyCare Appoints Industry Leader Matthew Levesque as CEO by Carolyn Helms | Jul 10, 2024 | Portfolio News
Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC by Carolyn Helms | Jul 8, 2024 | Portfolio News
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency by Carolyn Helms | Jul 2, 2024 | Portfolio News
Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046, an Oral KRASG12D-Selective Dual-State Allosteric Inhibitor, and Other Program Updates by Carolyn Helms | Jun 27, 2024 | Portfolio News
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes by Carolyn Helms | Jun 25, 2024 | Portfolio News
